Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123942432 | 12394243 | 2 | F | 20160214 | 20160704 | 20160523 | 20160712 | EXP | IT-PFIZER INC-2016261678 | PFIZER | 73.00 | YR | M | Y | 0.00000 | 20160712 | PH | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123942432 | 12394243 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 289 MG, SINGLE | Y | 76517 | 289 | MG | SOLUTION FOR INFUSION | ||||||
| 123942432 | 12394243 | 2 | SS | PEMETREXED | PEMETREXED | 1 | 547 MG, SINGLE | Y | 0 | 547 | MG | POWDER FOR INJECTION | |||||||
| 123942432 | 12394243 | 3 | C | JAKAFI | RUXOLITINIB | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | ||||||||
| 123942432 | 12394243 | 4 | C | PANTORC | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, UNK | 0 | 40 | MG | ||||||||
| 123942432 | 12394243 | 5 | C | ZYLORIC | ALLOPURINOL | 1 | Oral | 150 MG, UNK | 0 | 150 | MG | ||||||||
| 123942432 | 12394243 | 6 | C | OMNIC | TAMSULOSIN HYDROCHLORIDE | 1 | Oral | 0.4 MG, UNK | 0 | .4 | MG | ||||||||
| 123942432 | 12394243 | 7 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Oral | 25 MG, UNK | 0 | 25 | MG | ||||||||
| 123942432 | 12394243 | 8 | C | CARDIOASPIRIN | ASPIRIN | 1 | Oral | 100 MG, UNK | 0 | 100 | MG | ||||||||
| 123942432 | 12394243 | 9 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | Oral | 13.8 G, UNK | 0 | 13.8 | G |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123942432 | 12394243 | 1 | Lung neoplasm malignant |
| 123942432 | 12394243 | 2 | Lung neoplasm malignant |
| 123942432 | 12394243 | 3 | Myelofibrosis |
| 123942432 | 12394243 | 4 | Gastrooesophageal reflux prophylaxis |
| 123942432 | 12394243 | 5 | Hyperuricaemia |
| 123942432 | 12394243 | 6 | Benign prostatic hyperplasia |
| 123942432 | 12394243 | 7 | Depression |
| 123942432 | 12394243 | 8 | Thrombosis prophylaxis |
| 123942432 | 12394243 | 9 | Astringent therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123942432 | 12394243 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123942432 | 12394243 | Anaemia | |
| 123942432 | 12394243 | Cough | |
| 123942432 | 12394243 | Neutropenia | |
| 123942432 | 12394243 | Pyrexia | |
| 123942432 | 12394243 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123942432 | 12394243 | 1 | 20160208 | 20160208 | 0 | |
| 123942432 | 12394243 | 2 | 20160208 | 20160208 | 0 |